Ambee Pharmaceuticals PLC (DSE: AMBEEPHA)

Ambee Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 10, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	2,361	1,318	1,260	985	1,154	1,550
Market Cap Growth	52.37%	4.57%	27.92%	-14.60%	-25.58%	9.16%
Enterprise Value	2,773	1,629	1,521	1,202	1,377	1,662
Last Close Price	983.90	548.06	523.13	408.96	477.12	636.82
PE Ratio	221.08	144.70	155.79	-75.44	314.87	453.92
PS Ratio	11.51	6.65	6.96	9.95	4.04	4.83
PB Ratio	96.17	56.46	23.92	21.97	19.94	26.81
P/FCF Ratio	-27.22	-37.29	-16.87	-180.71	-90.96	39.71
P/OCF Ratio	-28.06	-37.40	-17.22	-180.71	-96.37	39.34
EV/Sales Ratio	13.51	8.22	8.40	12.14	4.83	5.17
EV/EBITDA Ratio	128.60	80.79	77.41	-718.93	75.98	59.48
EV/EBIT Ratio	210.33	123.64	102.35	-165.04	119.74	82.74
EV/FCF Ratio	-41.11	-46.08	-20.35	-220.45	-108.55	42.58
Debt / Equity Ratio	18.14	16.81	6.54	5.35	3.94	3.82
Debt / EBITDA Ratio	20.66	18.95	16.49	-	11.72	7.89
Debt / FCF Ratio	-6.60	-11.11	-4.62	-43.99	-17.96	5.65
Asset Turnover	0.39	0.39	0.39	0.23	0.69	0.76
Inventory Turnover	0.49	0.49	0.54	0.40	0.88	1.02
Quick Ratio	0.35	0.34	0.29	0.29	0.22	0.21
Current Ratio	0.90	0.88	0.92	0.87	0.89	0.88
Return on Equity (ROE)	30.43%	23.91%	16.53%	-25.34%	6.29%	5.64%
Return on Assets (ROA)	1.56%	1.62%	2.01%	-1.07%	1.73%	2.96%
Return on Capital (ROIC)	1.91%	2.02%	2.72%	-1.60%	2.55%	4.30%
Earnings Yield	0.45%	0.69%	0.64%	-1.32%	0.32%	0.22%
FCF Yield	-2.86%	-2.68%	-5.93%	-0.55%	-1.10%	2.52%
Dividend Yield	0.15%	0.27%	0.19%	-	0.31%	0.47%
Payout Ratio	29.77%	11.00%	18.61%	-	81.17%	316.61%
Total Shareholder Return	0.15%	0.27%	0.19%	-	0.31%	0.47%

Source: S&P Capital IQ. Standard template. Financial Sources.